Vaccinex, Inc. (VCNX) stock
VCNXOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2024, quarter ended Dec 31, 2024Last filing: 10-K on Apr 15, 2025
$1.00−0.01 (-0.99%)
Close on Oct 19, 2026Market cap $3.22MP/E –Yield –
Vaccinex operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Vaccinex's operating income for the twelve months ending Dec 31, 2024 was -$18.74M. For fiscal 2024 it was -$18.74M. The highest annual figure on record is -$18.74M in fiscal 2024.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -$18.74M | – |
| FY2023 | Dec 31, 2023 | -$22.89M | – |
| FY2022 | Dec 31, 2022 | -$19.91M | – |
| FY2021 | Dec 31, 2021 | -$22.49M | – |
| FY2020 | Dec 31, 2020 | -$28.33M | – |
| FY2019 | Dec 31, 2019 | -$32.02M | – |
| FY2018 | Dec 31, 2018 | -$27.28M | – |
| FY2017 | Dec 31, 2017 | -$21.10M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | -$3.39M | – |
| Q3 FY2024 | Sep 30, 2024 | -$4.55M | – |
| Q2 FY2024 | Jun 30, 2024 | -$5.72M | – |
| Q1 FY2024 | Mar 31, 2024 | -$5.07M | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.99M | – |
| Q3 FY2023 | Sep 30, 2023 | -$5.83M | – |
| Q2 FY2023 | Jun 30, 2023 | -$7.08M | – |
| Q1 FY2023 | Mar 31, 2023 | -$4.99M | – |
| Q4 FY2022 | Dec 31, 2022 | -$5.12M | – |
| Q3 FY2022 | Sep 30, 2022 | -$4.79M | – |
| Q2 FY2022 | Jun 30, 2022 | -$5.40M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.59M | – |
| Q4 FY2021 | Dec 31, 2021 | -$5.52M | – |
| Q3 FY2021 | Sep 30, 2021 | -$5.06M | – |
| Q2 FY2021 | Jun 30, 2021 | -$5.67M | – |
| Q1 FY2021 | Mar 31, 2021 | -$6.24M | – |
| Q4 FY2020 | Dec 31, 2020 | -$6.09M | – |
| Q3 FY2020 | Sep 30, 2020 | -$8.58M | – |
| Q2 FY2020 | Jun 30, 2020 | -$6.50M | – |
| Q1 FY2020 | Mar 31, 2020 | -$7.16M | – |
| Q4 FY2019 | Dec 31, 2019 | -$6.34M | – |
| Q3 FY2019 | Sep 30, 2019 | -$7.68M | – |
| Q2 FY2019 | Jun 30, 2019 | -$8.86M | – |
| Q1 FY2019 | Mar 31, 2019 | -$9.14M | – |
| Q4 FY2018 | Dec 31, 2018 | -$8.56M | – |
| Q3 FY2018 | Sep 30, 2018 | -$6.45M | – |
| Q2 FY2018 | Jun 30, 2018 | -$6.56M | – |
| Q1 FY2018 | Mar 31, 2018 | -$5.71M | – |
| Q4 FY2017 | Dec 31, 2017 | -$6.20M | – |
| Q3 FY2017 | Sep 30, 2017 | -$5.33M | – |
| Q2 FY2017 | Jun 30, 2017 | -$4.67M | – |
See a number that looks wrong?